Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
19 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
20 Feb 24
8-K
Tender and Support Agreement
12 Dec 23
8-K
Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate Update
14 Nov 23
8-K
Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update
14 Aug 23
8-K
Regulation FD Disclosure
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
8-K
Entry into a Material Definitive Agreement
23 May 23
8-K
Regulation FD Disclosure
22 May 23
8-K
Icosavax Reports First Quarter 2023 Financial Results and Provides Corporate Update
10 May 23
8-K
Icosavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
30 Mar 23
Registration and prospectus
15-12G
Securities registration termination
1 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
21 Feb 24
25-NSE
Exchange delisting
20 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 24
POS AM
Prospectus update (post-effective amendment)
20 Feb 24
SC 14D9/A
Tender offer solicitation (amended)
20 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
20 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
14 Feb 24
SC 14D9/A
Tender offer solicitation (amended)
14 Feb 24
SC 14D9/A
Tender offer solicitation (amended)
19 Jan 24
Other
EFFECT
Notice of effectiveness
21 Feb 24
EFFECT
Notice of effectiveness
30 Aug 22
CORRESP
Correspondence with SEC
25 Aug 22
UPLOAD
Letter from SEC
23 Aug 22
SEC STAFF
SEC staff action: Order
3 Aug 21
EFFECT
Notice of effectiveness
29 Jul 21
CERT
Certification of approval for exchange listing
27 Jul 21
CORRESP
Correspondence with SEC
26 Jul 21
CORRESP
Correspondence with SEC
26 Jul 21
CORRESP
Correspondence with SEC
16 Jul 21
Ownership
SC 13D/A
Qiming U.S. Healthcare GP II, LLC
21 Feb 24
SC 13D/A
RA CAPITAL MANAGEMENT, L.P.
21 Feb 24
4
Rajeev M. Shah
20 Feb 24
4
Adam K. Simpson
20 Feb 24
4
Amin Khan
20 Feb 24
4
Ann M Veneman
20 Feb 24
4
Cassia Cearley
20 Feb 24
4
HEIDI FIELDS
20 Feb 24
4
Jim Wassil
20 Feb 24
4
Thomas Joseph Russo
20 Feb 24